TRVI Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own TRVI shares is 120, representing 70.49% of the company's common stock.

BNP PARIBAS ARBITRAGE, SNC, in the last quarter, reduced its stake in TRVI by -84.44% restricting it's holding to 20.58 thousand shares of worth nearly $70.99K. STRS OHIO also lessened -5.75% of the TRVI shares from its portfolio, reducing its holding to 8.2 thousand shares of worth $28.00K. AMALGAMATED BANK also shunned TRVI shares holding by -61.36% last quarter which brought its holding to 1.4 thousand shares worth $5.00K.

As per its latest 13F filing, FMR LLC increased its stake in TRVI by 0.68% in the last quarter. The institutional holder raised its holding to 3.54 thousand shares having worth more than $12.20K. METROPOLITAN LIFE INSURANCE CO/NY also added 100% more shares of TRVI to its portfolio, raising its holding to 2.34 thousand shares of worth $8.06K. FARTHER FINANCE ADVISORS, LLC also increased its TRVI shares holding by 100% which brought its holding to 55 shares worth $185.00.

The insider with the most stakes in TRVI is New Enterprise Associates 16, L.P. , 10 percent owner at the company. Additionally, TRVI stock is highly held by NEA 16 GP, LLC and BASKETT FOREST among others.

Company executives, directors, and other insiders own 1.04% percent of Trevi Therapeutics, Inc.'s stock. Within the last six months, there have been 10 transaction(s) in which TRVI insiders have sold stock, totaling 113.74K shares. Insiders that have sold shares include GOOD JENNIFER L, MEEKER DAVID P, and SCIASCIA THOMAS.

There have been 0 transaction(s) during the past 6-months in which Trevi Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 2.3M Trevi Therapeutics, Inc. shares are held by insiders, which represents about 1.04% of TRVI stock.

TRVI 10 percent owner, New Enterprise Associates 16, L.P. holds the largest portfolio of the company's shares. TRVI shares owned by New total nearly 10.42 million.

BNP PARIBAS ARBITRAGE, SNC is the largest institutional owner in TRVI which holds 20.58 thousand shares worth $70.99K or 0.02% of the total TRVI shares outstanding followed by STRS OHIO with ownership of 8.2 thousand shares representing 0.01% of the TRVI ownership. LEGAL & GENERAL GROUP PLC is the third largest stakeholder with 3.97 thousand shares or 0% of the ownership worth more than $13.71M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the TRVI is concerned, it is a stock which is optionable.

Number of TRVI shares short is 4.13M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 89.37M shares of TRVI are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, TRVI has 47.77M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for TRVI is 4.53.